Shares of Celsion CLSN were halted in after-hours trading on Wednesday. The company said it would hold a conference call Thursday morning at 8 am to discuss the top-line results from its Phase III HEAT Study with ThermoDox.
The HEAT Study had received a Fast Track designation from the FDA and Orphan Drug status.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
